Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-18-000457

Chief Scientific Officer acquired 55,120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-21 Exercise or conversion : show line 1 in the form +55,120 $0.08 $4,410 55,120 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-05-21 Grant or award : show line 2 in the form Stock Options (option to buy) +50,016 50,016 D
2018-05-21 Exercise or conversion : show line 3 in the form Stock Options (option to buy) −55,120 0 D
Loading xslF345X03/edgar.xml…